How can small biotechnology companies help connect academic research with industry?

Small biotechnology companies play a vital role in translational medicine by serving as a bridge between academic research and the commercial pharmaceutical industry.

While academic researchers typically focus on identifying novel, creative solutions and basic scientific understanding, the commercial sector primarily directs its resources toward validating and commercializing known therapeutic entities. Small biotechnology enterprises help connect these two spheres by:12

• Bridging the Gap: They act as intermediaries that facilitate a balanced partnership, allowing the strengths of both sectors to complement one another.1
• Creating Feedback Loops: By fostering these partnerships, they help establish a positive feedback loop where clinical benefits inform new academic hypotheses, which subsequently lead to the development of innovative products in industry.1
• Expediting Development: They assist in the transfer of testable agents into clinical settings, which can lead to more rapid validation of new products and help reduce the high costs associated with preclinical testing.1

By operating in this space, these companies help overcome the fragmentation between basic science and clinical application, ultimately increasing the efficiency of biomedical discovery.1